Cyclacel Pharmaceuticals Inc (CYCC)
2.29
-0.05
(-2.14%)
USD |
NASDAQ |
May 17, 16:00
2.29
0.00 (0.00%)
After-Hours: 20:00
Cyclacel Pharmaceuticals Market Cap: 3.019M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 3.019M |
| May 16, 2024 | 3.085M |
| May 15, 2024 | 3.217M |
| May 14, 2024 | 3.744M |
| May 13, 2024 | 3.348M |
| May 10, 2024 | 2.992M |
| May 09, 2024 | 3.045M |
| May 08, 2024 | 3.058M |
| May 07, 2024 | 2.782M |
| May 06, 2024 | 2.729M |
| May 03, 2024 | 2.637M |
| May 02, 2024 | 3.283M |
| May 01, 2024 | 3.494M |
| April 30, 2024 | 2.795M |
| April 29, 2024 | 1.793M |
| April 26, 2024 | 1.991M |
| April 25, 2024 | 2.109M |
| April 24, 2024 | 3.032M |
| April 23, 2024 | 2.360M |
| April 22, 2024 | 2.307M |
| April 19, 2024 | 2.347M |
| April 18, 2024 | 2.439M |
| April 17, 2024 | 2.584M |
| April 16, 2024 | 2.202M |
| April 15, 2024 | 2.070M |
| Date | Value |
|---|---|
| April 12, 2024 | 2.320M |
| April 11, 2024 | 2.558M |
| April 10, 2024 | 2.702M |
| April 09, 2024 | 2.782M |
| April 08, 2024 | 2.782M |
| April 05, 2024 | 2.768M |
| April 04, 2024 | 2.891M |
| April 03, 2024 | 2.887M |
| April 02, 2024 | 2.795M |
| April 01, 2024 | 2.702M |
| March 28, 2024 | 2.782M |
| March 27, 2024 | 2.584M |
| March 26, 2024 | 2.531M |
| March 25, 2024 | 2.821M |
| March 22, 2024 | 2.884M |
| March 21, 2024 | 2.874M |
| March 20, 2024 | 2.966M |
| March 19, 2024 | 3.098M |
| March 18, 2024 | 3.309M |
| March 15, 2024 | 3.204M |
| March 14, 2024 | 3.290M |
| March 13, 2024 | 3.414M |
| March 12, 2024 | 3.271M |
| March 11, 2024 | 3.322M |
| March 08, 2024 | 3.480M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.793M
Minimum
Apr 29 2024
77.03M
Maximum
Mar 19 2021
20.82M
Average
13.13M
Median
Jan 22 2020
Market Cap Benchmarks
| Corvus Pharmaceuticals Inc | 143.24M |
| Oragenics Inc | 10.44M |
| Relmada Therapeutics Inc | 100.78M |
| Alpine Immune Sciences Inc | 4.457B |
| MAIA Biotechnology Inc | 72.28M |
Market Cap Related Metrics
| Price to Book Value | 4.974 |
| Price | 2.29 |
| Earnings Yield | -1.18K% |